Sangkhae Veena, Nemeth Elizabeta
Center for Iron Disorders, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
Center for Iron Disorders, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
Adv Nutr. 2017 Jan 17;8(1):126-136. doi: 10.3945/an.116.013961. Print 2017 Jan.
Iron is required for many biological processes but is also toxic in excess; thus, body iron balance is maintained through sophisticated regulatory mechanisms. The lack of a regulated iron excretory mechanism means that body iron balance is controlled at the level of absorption from the diet. Iron absorption is regulated by the hepatic peptide hormone hepcidin. Hepcidin also controls iron release from cells that recycle or store iron, thus regulating plasma iron concentrations. Hepcidin exerts its effects through its receptor, the cellular iron exporter ferroportin. Important regulators of hepcidin, and therefore of systemic iron homeostasis, include plasma iron concentrations, body iron stores, infection and inflammation, and erythropoiesis. Disturbances in the regulation of hepcidin contribute to the pathogenesis of many iron disorders: hepcidin deficiency causes iron overload in hereditary hemochromatosis and nontransfused β-thalassemia, whereas overproduction of hepcidin is associated with iron-restricted anemias seen in patients with chronic kidney disease, chronic inflammatory diseases, some cancers, and inherited iron-refractory iron deficiency anemia. This review summarizes our current understanding of the molecular mechanisms and signaling pathways involved in the control of hepcidin synthesis in the liver, a principal determinant of plasma hepcidin concentrations.
许多生物过程都需要铁,但铁过量时也具有毒性;因此,机体通过复杂的调节机制来维持铁平衡。由于缺乏一种受调控的铁排泄机制,这意味着机体的铁平衡是在饮食铁吸收水平上进行控制的。铁的吸收受肝脏肽激素铁调素的调节。铁调素还控制着回收或储存铁的细胞中铁的释放,从而调节血浆铁浓度。铁调素通过其受体——细胞铁输出蛋白铁转运蛋白发挥作用。铁调素以及全身铁稳态的重要调节因子包括血浆铁浓度、机体铁储存、感染与炎症,以及红细胞生成。铁调素调节紊乱会导致多种铁代谢疾病的发病机制:铁调素缺乏会导致遗传性血色素沉着症和未输血的β地中海贫血中铁过载,而铁调素过度产生则与慢性肾病、慢性炎症性疾病、某些癌症患者以及遗传性铁难治性缺铁性贫血患者中出现的铁限制性贫血有关。本综述总结了我们目前对肝脏中铁调素合成控制所涉及的分子机制和信号通路的理解,肝脏是血浆铁调素浓度的主要决定因素。